|
1
|
Zheng ZH, Hu JD, Chen YY, Lian XL, Zheng
HY, Zheng J and Lin MH: Effect of emodin on proliferation
inhibition and apoptosis induction in leukemic K562 cells. Zhongguo
Shi Yan Xue Ye Xue Za Zhi. 17:1434–1438. 2009.(In Chinese).
PubMed/NCBI
|
|
2
|
Lai MY, Hour MJ, Wing-Cheung Leung H, Yang
WH and Lee HZ: Chaperones are the target in aloe-emodin-induced
human lung nonsmall carcinoma H460 cell apoptosis. Eur J Pharmacol.
573:1–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai JM, Chang JT, Wen CL and Hsu SL:
Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax
mediated cytotoxicity in lung cancer cells. Eur J Pharmacol.
623:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pastor DM, Irby RB and Poritz LS: Tumor
necrosis factor alpha induces p53 up-regulated modulator of
apoptosis expression in colorectal cancer cell lines. Dis Colon
Rectum. 53:257–263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang SX, Steinberg SM, Nguyen D and Swain
SM: p53, HER2 and tumor cell apoptosis correlate with clinical
outcome after neoadjuvant bevacizumab plus chemotherapy in breast
cancer. Int J Oncol. 38:1445–1452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goel A, Fuerst F, Hotchkiss E and Boland
CR: Selenomethionine induces p53 mediated cell cycle arrest and
apoptosis in human colon cancer cells. Cancer Biol Ther. 5:529–535.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tu SP, Chi AL, Ai W, Takaishi S,
Dubeykovskaya Z, Quante M, Fox JG and Wang TC: p53 inhibition of
AP1-dependent TFF2 expression induces apoptosis and inhibits cell
migration in gastric cancer cells. Am J Physiol Gastrointest Liver
Physiol. 297:G385–G396. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y,
Yang G and Hong Y: Mutations of p53 and KRAS activate NF-κB to
promote chemoresistance and tumorigenesis via dysregulation of cell
cycle and suppression of apoptosis in lung cancer cells. Cancer
Lett. 357:520–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Machado-Silva A, Perrier S and Bourdon JC:
p53 family members in cancer diagnosis and treatment. Semin Cancer
Biol. 20:57–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Basu S and Murphy ME: p53 family members
regulate cancer stem cells. Cell Cycle. 15:1403–1404. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Becker K, Pancoska P, Concin N, Heuvel K
Vanden, Slade N, Fischer M, Chalas E and Moll UM: Patterns of p73
N-terminal isoform expression and p53 status have prognostic value
in gynecological cancers. Int J Oncol. 29:889–902. 2006.PubMed/NCBI
|
|
12
|
Castillo J, Goñi S, Latasa MU, Perugorría
MJ, Calvo A, Muntané J, Bioulac-Sage P, Balabaud C, Prieto J, Avila
MA and Berasain C: Amphiregulin induces the alternative splicing of
p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular
tumors. Gastroenterology. 137:1805–15, e1–4. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marrazzo E, Marchini S, Tavecchio M,
Alberio T, Previdi S, Erba E, Rotter V and Broggini M: The
expression of the DeltaNp73beta isoform of p73 leads to
tetraploidy. Eur J Cancer. 45:443–453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendoza M, Mandani G and Momand J: The
MDM2 gene family. Biomol Concepts. 5:9–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Momand J, Villegas A and Belyi VA: The
evolution of MDM2 family genes. Gene. 486:23–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Madhumalar A, Lee HJ, Brown CJ, Lane D and
Verma C: Design of a novel MDM2 binding peptide based on the p53
family. Cell Cycle. 8:2828–2836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson J, Lagowski J, Lawson S, Liu Y and
Kulesz-Martin M: p73 expression modulates p63 and Mdm2 protein
presence in complex with p53 family-specific DNA target sequence in
squamous cell carcinogenesis. Oncogene. 27:2780–2787. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo W, Ahmed KM, Hui Y, Guo G and Li JJ:
siRNA-mediated MDM2 inhibition sensitizes human lung cancer A549
cells to radiation. Int J Oncol. 30:1447–1452. 2007.PubMed/NCBI
|
|
19
|
Yu H, Zou Y, Jiang L, Yin Q, He X, Chen L,
Zhang Z, Gu W and Li Y: Induction of apoptosis in non-small cell
lung cancer by downregulation of MDM2 using pH-responsive
PMPC-b-PDPA/siRNA complex nanoparticles. Biomaterials.
34:2738–2747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma J, Peng J, Mo R, Ma S, Wang J, Zang L,
Li W and Fan J: Ubiquitin E3 ligase UHRF1 regulates p53
ubiquitination and p53-dependent cell apoptosis in clear cell Renal
Cell Carcinoma. Biochem Biophys Res Commun. 464:147–153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alhosin M, Abusnina A, Achour M, Sharif T,
Muller C, Peluso J, Chataigneau T, Lugnier C, Schini-Kerth VB,
Bronner C and Fuhrmann G: Induction of apoptosis by thymoquinone in
lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent
pathway which targets the epigenetic integrator UHRF1. Biochem
Pharmacol. 79:1251–1260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colley SM, Iyer KR and Leedman PJ: The RNA
coregulator SRA, its binding proteins and nuclear receptor
signaling activity. IUBMB Life. 60:159–164. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dai C, Shi D and Gu W: Negative regulation
of the acetyltransferase TIP60-p53 interplay by UHRF1
(ubiquitin-like with PHD and RING finger domains 1). J Biol Chem.
288:19581–19592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang CC and Cohn MA: UHRF1 is a sensor
for DNA interstrand crosslinks. Oncotarget. 7:3–4. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Delagoutte B, Lallous N, Birck C, Oudet P
and Samama JP: Expression, purification, crystallization and
preliminary crystallographic study of the SRA domain of the human
UHRF1 protein. Acta Crystallogr Sect F Struct Biol Cryst Commun.
64:922–925. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bronner C, Achour M, Arima Y, Chataigneau
T, Saya H and Schini-Kerth VB: The UHRF family: Oncogenes that are
drugable targets for cancer therapy in the near future? Pharmacol
Ther. 115:419–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh KB and Trigun SK: Apoptosis of
Dalton's lymphoma due to in vivo treatment with emodin is
associated with modulations of hydrogen peroxide metabolizing
antioxidant enzymes. Cell Biochem Biophys. 67:439–449. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Poupot M, Pont F and Fournié JJ: Profiling
blood lymphocyte interactions with cancer cells uncovers the innate
reactivity of human gamma delta T cells to anaplastic large cell
lymphoma. J Immunol. 174:1717–1722. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gujral S, Polampalli SN, Badrinath Y,
Kumar A, Subramanian PG, Nair R, Gupta S, Sengar M and Nair C:
Immunophenotyping of mature B-cell non Hodgkin lymphoma involving
bone marrow and peripheral blood: Critical analysis and insights
gained at a tertiary care cancer hospital. Leuk Lymphoma.
50:1290–1300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Emmrich S, Wang W, John K, Li W and Pützer
BM: Antisense gapmers selectively suppress individual oncogenic p73
splice isoforms and inhibit tumor growth in vivo. Mol Cancer.
8:612009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lau LM, Wolter JK, Lau JT, Cheng LS, Smith
KM, Hansford LM, Zhang L, Baruchel S, Robinson F and Irwin MS:
Cyclooxygenase inhibitors differentially modulate p73 isoforms in
neuroblastoma. Oncogene. 28:2024–2033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Graça I, Sousa EJ, Baptista T, Almeida M,
Ramalho-Carvalho J, Palmeira C, Henrique R and Jerónimo C:
Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in
human prostate cancer cells. Curr Pharm Des. 20:1803–1811. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hopfer O, Komor M, Koehler IS, Freitag C,
Schulze M, Hoelzer D, Thiel E and Hofmann WK: Aberrant promotor
methylation in MDS hematopoietic cells during in vitro lineage
specific differentiation is differently associated with DNMT
isoforms. Leuk Res. 33:434–442. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu K, Zhan M and Zheng P: Loss of p73
expression in six non-small cell lung cancer cell lines is
associated with 5′CpG island methylation. Exp Mol Pathol. 84:59–63.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe T, Huang H, Nakamura M,
Wischhusen J, Weller M, Kleihues P and Ohgaki H: Methylation of the
p73 gene in gliomas. Acta Neuropathol. 104:357–362. 2002.PubMed/NCBI
|
|
37
|
Lai J, Nie W, Zhang W, Wang Y, Xie R, Wang
Y, Gu J, Xu J, Song W, Yang F, et al: Transcriptional regulation of
the p73 gene by Nrf-2 and promoter CpG methylation in human breast
cancer. Oncotarget. 5:6909–6922. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rizzo MG, Giombini E, Diverio D, Vignetti
M, Sacchi A, Testa U, Lo-Coco F and Blandino G: Analysis of p73
expression pattern in acute myeloid leukemias: Lack of DeltaN-p73
expression is a frequent feature of acute promyelocytic leukemia.
Leukemia. 18:1804–1809. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawano S, Miller CW, Gombart AF, Bartram
CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E and Koeffler
HP: Loss of p73 gene expression in leukemias/lymphomas due to
hypermethylation. Blood. 94:1113–1120. 1999.PubMed/NCBI
|
|
40
|
El-Osta A: DNMT cooperativity-the
developing links between methylation, chromatin structure and
cancer. Bioessays. 25:1071–1084. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peng DF, Kanai Y, Sawada M, Ushijima S,
Hiraoka N, Kitazawa S and Hirohashi S: DNA methylation of multiple
tumor-related genes in association with overexpression of DNA
methyltransferase 1 (DNMT1) during multistage carcinogenesis of the
pancreas. Carcinogenesis. 27:1160–1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J,
Koseki H and Wong J: UHRF1 targets DNMT1 for DNA methylation
through cooperative binding of hemi-methylated DNA and methylated
H3K9. Nat Commun. 4:15632013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sharif J, Muto M, Takebayashi S, Suetake
I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T,
Okamura K, et al: The SRA protein Np95 mediates epigenetic
inheritance by recruiting Dnmt1 to methylated DNA. Nature.
450:908–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hu L, Li Z, Wang P, Lin Y and Xu Y:
Crystal structure of PHD domain of UHRF1 and insights into
recognition of unmodified histone H3 arginine residue 2. Cell Res.
21:1374–1378. 2011. View Article : Google Scholar : PubMed/NCBI
|
